J&J single-dose vaccine 'effective against Delta variant'
The President and CEO of the South African Medical Research Council, Professor Glenda Gray, has assured South Africans that the single-dose Johnson & Johnson vaccine is effective against the Delta variant, which is currently dominant in the country.

